 |
MRG-106 oligonucleotide inhibitor of microRNA miR-155-5p |
|---|---|
| Trade Name | |
| Orphan Indication | Mycosis fungoides |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-30 00:00:00 |
| Sponsor | miRagen Therapeutics, Inc.;6200 Lookout Road, Suite 100;Boulder, Colorado, 80301 |
